Main > ONCOLOGY (**) > Multiple Myeloma R/R *** > Treatment > USA. A. Proteasome Inhibitor Inj.>

---

USA. A. Proteasome Inhibitor Inj.>'s subsections
(*) CN Approval Date: 2021. 07.09.
(*) USA Approval Dates: ?
>Alone>Received>1 Prior Treat.
>Combi.>+DaratumuMAb+Dexamethasone>
>Combi.>+Dexamethasone or
>Combi.>+Dexamethasone+Lenalidomide
>Combi.>Received 1-3 Prior Treat.
Company
Company Licensee>CN:
Company Licensee>JP:
Generic Name: Carfilzomib
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 40
Patent>UpDate: 2017. 09.05
TradeMark
TradeMark Web-Site

USA. A. Proteasome Inhibitor Inj.>'s products
This section has no products